Restructuring Charges

12 Months Ended

Dec. 31, 2022

RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies. Restructuring activity includes severance, lease exit costs, and related consulting fees. The following reflects our restructuring activity (in millions):


	Year Ended
	December 31, 2022						December 31, 2021		December 31, 2020
	Supply Chain Reinvention(1)		Other Initiatives(1)		Total		Total		Total
Beginning balance	$	—	$	6.9	$	6.9	$	9.1	$	19.5
Additional charges	24.3		18.2		42.5		16.9		3.2
Payments	(22.1)		(7.7)		(29.8)		(19.0)		(14.2)
Non-cash adjustments	—		0.2		0.2		(0.1)		0.6
Ending balance	$	2.2	$	17.6	$	19.8	$	6.9	$	9.1

(1) Supply Chain Reinvention was announced in 2022 and as a result separately disclosed from Other Initiatives.

The charges incurred during the year ended December 31, 2022 were primarily associated with actions taken on supply chain restructuring and HRA integration activities. The charges incurred during the year ended December 31, 2021, were primarily associated with actions taken to streamline the organization. The charges incurred during the year ended December 31, 2020 were also primarily associated with actions takes to streamline the organization.

Of the amount recorded during the year ended December 31, 2022, $29.4 million was related to our CSCI segment, due primarily to supply chain restructuring and HRA Pharma integration initiatives and $2.5 million was related to our CSCA segment, due primarily to actions taken to streamline the organization. Of the amount recorded during the year ended December 31, 2021, $6.1 million was related to our CSCI segment, also due primarily to various integration initiatives, and $7.9 million was allocated to our CSCA segment, due primarily to actions taken to streamline the organization. For year ended December 31, 2020, $1.4 million related to our CSCI segment also due primarily to various integration initiatives. The remaining charges for all years were reported in our Unallocated segment. There were no other material restructuring programs in any of the periods presented.

All charges are recorded in Restructuring expense on the Consolidated Financial Statements. The remaining $19.8 million liability for employee severance benefits and accrued consulting fees is expected to be paid within the next year.